Zurich Cantonal Bank
AZN icon

Zurich Cantonal Bank’s AstraZeneca AZN Stock Holding History

Zurich Cantonal Bank’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352M Sell
1,878,727
-114,035
-6% -$21.4M 0.67% 21
2026
Q1 		$386M Buy
+1,992,762
New +$384M 0.84% 16
2025
Q3 		– Sell
-75
Closed -$10.5K – 2553
2025
Q2 		$10.5K Hold
75
– – ﹤0.01% 2516
2025
Q1 		$11K Hold
75
– – ﹤0.01% 2588
2024
Q4 		$9.83K Hold
75
– – ﹤0.01% 2608
2024
Q3 		$11.7K Hold
75
– – ﹤0.01% 2610
2024
Q2 		$11.7K Hold
75
– – ﹤0.01% 2613
2024
Q1 		$10.2K Sell
75
-2,471
-97% -$327K ﹤0.01% 2650
2023
Q4 		$343K Buy
2,546
+1,537
+152% +$200K ﹤0.01% 1758
2023
Q3 		$137K Hold
1,009
– – ﹤0.01% 2196
2023
Q2 		$144K Hold
1,009
– – ﹤0.01% 2128
2023
Q1 		$140K Sell
1,009
-76
-7% -$10.2K ﹤0.01% 2087
2022
Q4 		$147K Sell
1,085
-4,861
-82% -$610K ﹤0.01% 2018
2022
Q3 		$652K Hold
5,946
– – ﹤0.01% 1022
2022
Q2 		$786K Buy
5,946
+643
+12% +$84.4K ﹤0.01% 962
2022
Q1 		$704K Buy
5,303
+266
+5% +$31.9K ﹤0.01% 1123
2021
Q4 		$587K Hold
5,037
– – ﹤0.01% 1325
2021
Q3 		$605K Buy
+5,037
New +$586K ﹤0.01% 1175

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Zurich Cantonal Bank's AZN Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its AstraZeneca (AZN) stake by 5.7% in Q2 2026, selling an estimated $21.4M and leaving 1,878,727 shares worth $352M. The position accounts for 0.67% of the portfolio, ranked #21.

Zurich Cantonal Bank first reported a position in AZN in Q3 2021 and has held it in 18 quarters since. The position peaked at $386M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Zurich Cantonal Bank held 1,878,727 shares of AstraZeneca worth $352M as of Q2 2026.
  • Zurich Cantonal Bank sold 114,035 AstraZeneca shares in Q2 2026, an estimated $21.4M.
  • AstraZeneca made up 0.67% of Zurich Cantonal Bank's portfolio in Q2 2026, its #21 holding.
  • Zurich Cantonal Bank first reported a position in AstraZeneca in Q3 2021 and has held it in 18 quarters since.
  • Zurich Cantonal Bank's AstraZeneca position peaked at $386M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.